Task: Answer Verification
Input (English): Question: Does vorapaxar , an oral PAR-1 receptor antagonist , affect the pharmacokinetics of rosiglitazone?
Answer: Coadministration of vorapaxar with rosiglitazone or drugs metabolized via CYP2C8 is unlikely to cause a significant pharmacokinetic interaction.
Output (English): no